Source comparison
Comparison: BPC-157 vs Standard Gut Healing Protocols
BPC-157 (250–500 mcg daily) VEGF upregulation, growth hormone receptor modulation, nitric oxide pathway activation 4–8 weeks for mucosal healing; 2–4 weeks for symptom reduction Preclinical animal models (strong); human case reports (limited) Most direct mecha
This comparison does not assign a generated winner or score.
- BPC-157 (250–500 mcg daily)
- VEGF upregulation, growth hormone receptor modulation, nitric oxide pathway activation
- 4–8 weeks for mucosal healing; 2–4 weeks for symptom reduction
- Preclinical animal models (strong); human case reports (limited)
- Most direct mechanism for structural epithelial repair. Addresses barrier breakdown at the gene expression level, not just symptom suppression
- L-Glutamine (5–10g daily)
- Enterocyte fuel substrate, supports tight junction maintenance
- 8–12 weeks
- Mixed human trials; some positive RCTs in critically ill populations
- Supports repair indirectly by providing cellular energy. Doesn't upregulate tight junction proteins or angiogenesis
- Zinc Carnosine (75–150mg daily)
- Mucosal adherence, local cytoprotection, prostaglandin synthesis
- Moderate human evidence in gastric ulcer healing
- Effective for gastric mucosa but limited evidence for small intestinal or colonic permeability
- Proton Pump Inhibitors (omeprazole 20–40mg daily)
- Gastric acid suppression
- 4–8 weeks for ulcer healing
- Strong human RCT evidence for gastric and duodenal ulcers
- Gold standard for acid-related ulcers. No effect on leaky gut or IBS unless GERD is a comorbidity
- Bone Broth / Collagen Peptides (10–20g daily)
- Provides glycine, proline, hydroxyproline for connective tissue synthesis
- 12+ weeks
- Weak; mostly anecdotal
- May support collagen synthesis indirectly but no evidence for tight junction restoration or mucosal repair